DRACO (Double-stranded RNA [dsRNA] Activated Caspase Oligomerizer) is a broad spectrum antiviral therapy created at MIT's Lincoln laboratory. For the layman, DRACO is to viruses, all viruses, as Penicillin is to bacteria. Current testing has been limited by funding, but has already been shown to cure (not just treat) many major viruses such as Dengue fever and H1N1 influenza. In the words of its creator Dr. Todd Rider, "DRACO has the potential to revolutionize the treatment and prevention of virtually all viral diseases, including everything from the common cold to Ebola." Potential benefits for the entire world can't be overstated. Imagine making a routine 15 minute visit to your local clinic to cure your HIV, Flu, Herpes or even some cancers!
http://www.ll.mit.edu/news/DRACO.html
This is historical material “frozen in time”. The website is no longer updated and links to external websites and some internal pages may not work.
